Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Low dose valproic acid treatment caused hair loss in a young patient.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Esomeprazole can cause hepatitis.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Ritlecitinib works well and is safe for treating alopecia areata.

Baricitinib is the most effective treatment for alopecia areata.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Upadacitinib effectively treated severe hair loss in a child.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Tofacitinib treatment is used for teenagers with alopecia areata.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Using finasteride with TIP extends time off period for prostate cancer patients.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.